DailyDoctor Archive Specialties Get app
All neurology briefings

The edition · Neurology

Atorvastatin in over-70s cut cardiovascular events by 30% but did not extend disability-free survival

STAREE settles one half of the statin question in older adults; a Korean registry shows recurrence after artery dissection is concentrated in the first week; and higher p-tau217 went with worse cognition in late-onset epilepsy.

The edition in brief

In STAREE, 9,971 community-dwelling adults aged 70 or over without cardiovascular disease, diabetes or dementia were randomised to atorvastatin 40 mg or placebo for a median 5.9 years. Major cardiovascular events (a composite that includes stroke) fell (HR 0.70, 0.61 to 0.82), but the composite of death, dementia or persistent disability did not (HR 0.94, 0.84 to 1.05). In a Korean national registry of 711 patients with craniocervical artery dissection presenting within seven days, recurrent ischaemic stroke was 8.7% on day 1, 17.4% by one week and 19.9% at one year; a double lumen and stenosis without dilatation predicted recurrence, while intracranial versus extracranial location did not. In 85 patients with late-onset unexplained epilepsy, higher plasma p-tau217 was associated with worse cognition, especially with drug-refractory seizures, with about a quarter of the association statistically accounted for by sleep spindle coupling. A Brain review warns that the 2024 McDonald criteria, with more routes to a multiple sclerosis diagnosis, raise the risk of misdiagnosis outside expert centres.

In this edition
01
Clinical update

After craniocervical dissection, one in five had a recurrent stroke within a year, mostly in the first week

Treat the first week after craniocervical dissection as the high-risk period, and read the vessel imaging for double lumen and stenosis.

2 min · NeurologyRead →
Primary outcome
Recurrent ischaemic stroke at 1 year
Effect
8.7% day 1, 17.4% week 1, 19.9% year 1; double lumen aHR 1.87 (1.15–3.04)
02Research

In late-onset unexplained epilepsy, higher p-tau217 went with worse cognition and disrupted sleep

Treat late-onset unexplained epilepsy as a possible early sign of Alzheimer disease: test cognition and consider biomarkers.

1 min · NeurologyRead →
03Clinical update

More routes to an MS diagnosis under 2024 McDonald criteria bring more room for misdiagnosis

Use the 2024 McDonald criteria with a typical clinical picture and good-quality MRI, and seek an expert opinion before starting treatment when either is missing.

1 min · Brain : a journal of neurologyRead →
04Pearl

New seizures after 55 with a clean MRI deserve a cognitive baseline

In late-onset non-lesional epilepsy, a cognitive screen at diagnosis is the baseline you will need later.

1 minRead →
05Practice changer

Atorvastatin in healthy over-70s cut cardiovascular events but not death, dementia or disability

Consider a statin for vascular prevention in healthy older adults after discussing benefits and side effects; do not present it as protection against dementia or disability.

2 min · The New England journal of medicineRead →

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for neurology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free